Vical develops biopharmaceutical products for the prevention and treatment of chronic or life-threatening infectious diseases, based on our patented DNA delivery technologies and other therapeutic approaches.

RECENT NEWS

October 29, 2018 Vical Reports Third Quarter 2018 Financial and Operational Results
August 23, 2018 Vical to Present at the 20th Annual Rodman & Renshaw Global Investment Conference

October 29, 2018
Vical Reports Third Quarter 2018 Financial and Operational Results

August 23, 2018
Vical to Present at the 20th Annual Rodman & Renshaw Global Investment Conference

EVENTS & PRESENTATIONS

September 5, 2018 Rodman & Renshaw 20th Annual Global Investment Conference View the Webcast
May 3, 2018 Vical Incorporated 1Q18 Financial Results Conference Call View the Webcast

September 5, 2018
Rodman & Renshaw 20th Annual Global Investment Conference

May 3, 2018
Vical Incorporated 1Q18 Financial Results Conference Call

PRODUCT PIPELINE

Privacy Policy
Terms of Use
Site Map

P. 858 646 1100 10390 Pacific Center Court, San Diego, California 92121

This link to a non-Vical website is provided as a resource. Vical assumes no responsibility for content not provided by Vical, or for practices or standards of any non-Vical websites.